Fed up with the blame game on insulin prices, lawmakers say enough is enough

The finger-pointing between pharma companies and pharmacy benefits managers went to Washington Wednesday, when a congressional committee questioned the two sides about the rising cost of insulin. And amid some familiar arguments, the lawmakers issued one decree: Something's got to give.